BiomX (PHGE) Current Deferred Revenue (2021 - 2024)

BiomX has disclosed Current Deferred Revenue across 4 years of filings, most recently posting $2.0 million for Q3 2024.

• In Q3 2024, Current Deferred Revenue changed N/A year-over-year to $2.0 million; the TTM figure through Sep 2024 stood at $2.0 million (changed N/A YoY), while the FY2023 annual figure was $28000.0, changed N/A from the prior year.
• Current Deferred Revenue came in at $2.0 million for Q3 2024 at BiomX, roughly flat from $2.0 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $2.0 million in Q4 2021 to a low of $28000.0 in Q4 2023.
• Average Current Deferred Revenue over 4 years is $1.6 million, with a median of $2.0 million recorded in 2021.